Waddell & Reed Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-762,764
| Closed | -$65.3M | – | 458 |
|
|
2019
Q2 | $65.3M | Sell |
762,764
-1,761,209
| -70% | -$151M | 0.16% | 173 |
|
|
2019
Q1 | $224M | Sell |
2,523,973
-336,902
| -12% | -$29.9M | 0.56% | 41 |
|
|
2018
Q4 | $244M | Sell |
2,860,875
-376,063
| -12% | -$32M | 0.69% | 33 |
|
|
2018
Q3 | $314M | Sell |
3,236,938
-100,408
| -3% | -$9.74M | 0.7% | 30 |
|
|
2018
Q2 | $314M | Buy |
3,337,346
+160,247
| +5% | +$15.1M | 0.73% | 27 |
|
|
2018
Q1 | $258M | Buy |
3,177,099
+729,223
| +30% | +$59.1M | 0.58% | 40 |
|
|
2017
Q4 | $218M | Buy |
2,447,876
+66,102
| +3% | +$5.89M | 0.48% | 52 |
|
|
2017
Q3 | $222M | Buy |
2,381,774
+1,241,693
| +109% | +$116M | 0.49% | 55 |
|
|
2017
Q2 | $104M | Buy |
1,140,081
+8,678
| +0.8% | +$788K | 0.23% | 119 |
|
|
2017
Q1 | $99.3M | Sell |
1,131,403
-23,021
| -2% | -$2.02M | 0.21% | 130 |
|
|
2016
Q4 | $95.6M | Sell |
1,154,424
-23,522
| -2% | -$1.95M | 0.21% | 132 |
|
|
2016
Q3 | $109M | Buy |
1,177,946
+70,441
| +6% | +$6.52M | 0.23% | 120 |
|
|
2016
Q2 | $86.2M | Buy |
1,107,505
+71,710
| +7% | +$5.58M | 0.18% | 145 |
|
|
2016
Q1 | $85.4M | Sell |
1,035,795
-56,596
| -5% | -$4.67M | 0.16% | 159 |
|
|
2015
Q4 | $114M | Buy |
1,092,391
+1,198
| +0.1% | +$126K | 0.19% | 137 |
|
|
2015
Q3 | $115M | Sell |
1,091,193
-372,454
| -25% | -$39.2M | 0.19% | 133 |
|
|
2015
Q2 | $200M | Buy |
1,463,647
+22,481
| +2% | +$3.07M | 0.29% | 98 |
|
|
2015
Q1 | $180M | Sell |
1,441,166
-78,772
| -5% | -$9.82M | 0.25% | 100 |
|
|
2014
Q4 | $137M | Sell |
1,519,938
-110,000
| -7% | -$9.94M | 0.19% | 129 |
|
|
2014
Q3 | $118M | Buy |
1,629,938
+33,976
| +2% | +$2.45M | 0.16% | 146 |
|
|
2014
Q2 | $99.3M | Buy |
1,595,962
+590,149
| +59% | +$36.7M | 0.15% | 162 |
|
|
2014
Q1 | $68.6M | Buy |
1,005,813
+905,813
| +906% | +$61.8M | 0.1% | 195 |
|
|
2013
Q4 | $7.03M | Buy |
+100,000
| New | +$7.03M | 0.01% | 472 |
|